Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$915M |
| 2 |
Meta Platforms (Facebook)
META
|
+$693M |
| 3 |
Salesforce
CRM
|
+$618M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
Nike
NKE
|
+$545M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$1.51B |
| 2 |
Pfizer
PFE
|
+$1.43B |
| 3 |
UBS Group
UBS
|
+$588M |
| 4 |
HSBC
HSBC
|
+$537M |
| 5 |
Procter & Gamble
PG
|
+$439M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.07% |
| 2 | Consumer Discretionary | 10.99% |
| 3 | Financials | 10.93% |
| 4 | Healthcare | 10.39% |
| 5 | Communication Services | 6.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LSI
301
DELISTED
Life Storage, Inc.
LSI
| $7.04M | 0.01% |
111,662
-118,167
| -51% | -$8.44M |
|
302
ACI Worldwide
ACIW
$5.42B
| $6.71M | 0.01% |
278,000
-150,206
| -35% | -$4.79M |
|
303
Nucor
NUE
$62.1B
| $6.62M | 0.01% |
183,844
+21,487
| +13% | +$954K |
|
304
iShares Global Healthcare ETF
IXJ
$4.18B
| $6.52M | 0.01% |
107,055
+46,409
| +77% | +$3.06M |
|
305
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.51B
| $6.52M | 0.01% |
359,313
-449,783
| -56% | -$9.27M |
|
306
3M
MMM
$94.3B
| $6.47M | 0.01% |
56,653
-33,710
| -37% | -$4.43M |
|
307
Materion
MTRN
$6.04B
| $6.41M | 0.01% |
183,035
-6,244
| -3% | -$310K |
|
|
TPH
308
DELISTED
Tri Pointe Homes
TPH
| $6.35M | 0.01% |
723,760
-274,954
| -28% | -$4.02M |
|
309
Lowe's Companies
LOW
$125B
| $6.22M | 0.01% |
72,243
-44
| -0.1% | -$4.81K |
|
|
B
310
DELISTED
Barnes Group Inc.
B
| $5.98M | 0.01% |
143,000
-56,000
| -28% | -$3.16M |
|
311
Independent Bank
INDB
$3.97B
| $5.97M | 0.01% |
92,830
+2,537
| +3% | +$181K |
|
312
iShares MSCI ACWI ETF
ACWI
$33.5B
| $5.77M | 0.01% |
92,232
+23,171
| +34% | +$1.72M |
|
313
Ligand Pharmaceuticals
LGND
$6.36B
| $5.7M | 0.01% |
125,589
-13,755
| -10% | -$780K |
|
314
Vertex Pharmaceuticals
VRTX
$126B
| $5.65M | 0.01% |
23,751
+1,398
| +6% | +$321K |
|
315
Neurocrine Biosciences
NBIX
$16.6B
| $5.59M | 0.01% |
64,567
-2,208
| -3% | -$216K |
|
316
LivaNova
LIVN
$4.2B
| $5.56M | 0.01% |
122,949
-55,000
| -31% | -$3.56M |
|
|
EPAY
317
DELISTED
Bottomline Technologies Inc
EPAY
| $5.56M | 0.01% |
151,705
-3,943
| -3% | -$182K |
|
318
Huazhu Hotels Group
HTHT
$13B
| $5.47M | 0.01% |
190,366
-19,778
| -9% | -$673K |
|
319
Carpenter Technology
CRS
$28.4B
| $5.34M | 0.01% |
273,966
-65,086
| -19% | -$2.43M |
|
320
UFP Industries
UFPI
$5.19B
| $5.24M | 0.01% |
141,012
+7,945
| +6% | +$365K |
|
321
Global Payments
GPN
$22.8B
| $5.24M | 0.01% |
36,341
-4,064
| -10% | -$743K |
|
322
TechnipFMC
FTI
$27.3B
| $5.13M | 0.01% |
1,022,065
+56,408
| +6% | +$619K |
|
323
iShares ESG Aware USD Corporate Bond ETF
SUSC
$1.29B
| $5.03M | 0.01% |
195,512
+2,759
| +1% | +$72.8K |
|
|
PCH
324
DELISTED
PotlatchDeltic
PCH
| $4.98M | 0.01% |
158,644
-13,813
| -8% | -$535K |
|
325
Revvity
RVTY
$12.8B
| $4.94M | 0.01% |
65,573
-1,341
| -2% | -$119K |
|
Similar funds
Ken Fisher's Q1 2020 Portfolio in Review
As of Q1 2020, Ken Fisher held 982 positions worth $80.6B, down 19% from $99B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q1 2020 filing shows 84 new, 262 increased, 421 reduced and 116 closed positions. Its largest new stake was Advanced Micro Devices: 7,132,669 shares worth $324M. The largest sale was Johnson & Johnson, an estimated $1.51B.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
- Ken Fisher's largest Q1 2020 buy was Advanced Micro Devices: 7,132,669 shares worth $324M.
- Ken Fisher added most to Mastercard in Q1 2020, an estimated $915M increase.
- Ken Fisher's biggest Q1 2020 reduction was Johnson & Johnson, cutting an estimated $1.51B.
- Ken Fisher fully exited Ambev in Q1 2020, selling an estimated $89.9M.
- Ken Fisher's ten largest holdings make up 31% of its $80.6B portfolio in Q1 2020.
- Ken Fisher opened 84 new positions and closed 116 in Q1 2020.
- Ken Fisher's portfolio value fell 19% quarter-over-quarter to $80.6B.
Based on Fisher Asset Management's 13F filing for Q1 2020, filed 28 Apr 2020.